<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9305697</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8786</journal-id>
<journal-id journal-id-type="nlm-ta">Osteoarthritis Cartilage</journal-id>
<journal-id journal-id-type="iso-abbrev">Osteoarthr. Cartil.</journal-id>
<journal-title-group>
<journal-title>Osteoarthritis and cartilage</journal-title>
</journal-title-group>
<issn pub-type="ppub">1063-4584</issn>
<issn pub-type="epub">1522-9653</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30081074</article-id>
<article-id pub-id-type="pmc">6245598</article-id>
<article-id pub-id-type="doi">10.1016/j.joca.2018.07.012</article-id>
<article-id pub-id-type="manuscript">NIHMS992829</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Fisch</surname>
<given-names>Kathleen M.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Gamini</surname>
<given-names>Ramya</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Alvarez-Garcia</surname>
<given-names>Oscar</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akagi</surname>
<given-names>Ryuichiro</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saito</surname>
<given-names>Masahiko</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muramatsu</surname>
<given-names>Yuta</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sasho</surname>
<given-names>Takahisa</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koziol</surname>
<given-names>James A.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Andrew I.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lotz</surname>
<given-names>Martin K.</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Center for Computational Biology and Bioinformatics, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA</aff>
<aff id="A2"><label>2</label>Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA</aff>
<aff id="A3"><label>3</label>Department of Orthopaedic Surgery, Chiba University Hospital 1-8-1 Inohana, Chuo-ku, Chiba, Japan </aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Dr. Lotz had full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
<p id="P3">Study conception and design: Fisch, Gamini, Alvarez-Garcia, Sasho, Su, Lotz</p>
<p id="P4">Acquisition of data: Saito, Akagi, Muramatsu, Alvarez-Garcia</p>
<p id="P5">Analysis and interpretation of data: Fisch, Gamini, Alvarez-Garcia, Sasho, Koziol, Su, Lotz</p>
</fn>
<corresp id="CR1"><bold>Corresponding Author:</bold> Martin K. Lotz, Department of Molecular Medicine, MEM-161, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA, <email>mlotz@scripps.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P44">COMPETING FINANCIAL INTERESTS</p>
<p id="P45">Martin K. Lotz and Andrew Su receive grant support from NIH.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>26</volume>
<issue>11</issue>
<fpage>1531</fpage>
<lpage>1538</lpage>
<!--elocation-id from pubmed: 10.1016/j.joca.2018.07.012-->
<abstract id="ABS1">
<sec id="S1">
<title>Objective</title>
<p id="P6">Osteoarthritis (OA) is the most prevalent joint disease. As disease-modifying therapies are not available, novel therapeutic targets need to be discovered and prioritized for their importance in mediating the abnormal phenotype of cells in OA-affected joints. Here, we generated a genome-wide molecular profile of OA to elucidate regulatory mechanisms of OA pathogenesis and to identify possible therapeutic targets using integrative analysis of mRNA-sequencing data obtained from human knee cartilage.</p>
</sec>
<sec id="S2">
<title>Design</title>
<p id="P7">RNA-sequencing (RNA-seq) was performed on 18 normal and 20 OA human knee cartilage tissues. RNA-seq datasets were analysed to identify genes, pathways and regulatory networks that were dysregulated in OA.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P8">RNA-seq data analysis revealed 1332 differentially expressed (DE) genes between OA and non-OA samples, including known and novel transcription factors (TFs). Pathway analysis identified 15 significantly perturbed pathways in OA with ECM-related, PI3K-Akt, HIF-1, FoxO and circadian rhythm pathways being the most significantly dysregulated. We selected differentially expressed TFs that are enriched for regulating DE genes in OA and prioritized these transcription factors by creating a cartilage-specific interaction subnetwork. This analysis revealed 8 TFs, including JUN, EGR1, JUND, FOSL2, MYC, KLF4, RELA, and FOS that both target large numbers of dysregulated genes in OA and are themselves suppressed in OA.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P9">We identified a novel subnetwork of dysregulated TFs that represent new mediators of abnormal gene expression and promising therapeutic targets in OA.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Cartilage</kwd>
<kwd>gene expression</kwd>
<kwd>transcription factors</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>